Actively Recruiting

Age: 18Years +
All Genders
NCT07137260

Digital Assessment of Real-World Walking Activity in Pulmonary Hypertension: A Prospective Multicenter Trial

Led by Simon Jäger · Updated on 2025-08-22

77

Participants Needed

4

Research Sites

153 weeks

Total Duration

On this page

Sponsors

S

Simon Jäger

Lead Sponsor

K

Klinikum Nürnberg

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this observational study is to validate digital mobility outcomes for monitoring the treatment and disease progression in adult patients with pulmonary hypertension. The main question it aims to answer is: -Do digital mobility outcomes (measured digital endpoints characterizing walking behavior) correlate with measures of precapillary pulmonary pressure as assessed by right heart catheterization? Participants will be asked to wear a small sensor on the lower back for one week at a time for a total of 3 times: at diagnosis and follow-up visits at 3-6 months and again at 6-12 months. Follow-up visits are scheduled by the treating clinician. At the end of the study participants can choose to receive feedback on the sensor measurements.

CONDITIONS

Official Title

Digital Assessment of Real-World Walking Activity in Pulmonary Hypertension: A Prospective Multicenter Trial

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Pulmonary hypertension confirmed by right heart catheterization
  • Presence of precapillary pulmonary hypertension at recruitment, defined as mean pulmonary arterial pressure (MAP) 20 mmHg, pulmonary arterial wedge pressure (PAWP)  15 mmHg, and pulmonary vascular resistance (PVR) > 2 Wood units
  • Follow-up visit scheduled at 3, 6, or 12 months after right heart catheterization
  • Independent walking without assistance and 6-minute walking distance greater than 100 meters
  • WHO Functional Class I-III
  • Ability to provide informed consent and participate in study procedures
  • Willingness to wear the Axivity AX6 Sensor for 7 days
Not Eligible

You will not qualify if you...

  • Hospitalization for a lung disease within 30 days before study recruitment
  • Neurological or orthopedic disease limiting walking ability
  • Acute pain limiting walking ability
  • Poor vision limiting walking ability
  • Terminal illness with life expectancy less than 1 year
  • Ongoing treatment for cancer
  • Acute psychosis or other severe psychiatric illness
  • Substance dependence

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

Robert Bosch Hospital

Stuttgart, Baden-Wurttemberg, Germany, 70376

Actively Recruiting

2

Internal Medicine Clinic V, Ludwig-Maximilians-University Clinic

Munich, Bavaria, Germany, 81377

Actively Recruiting

3

Klinikum Nuremberg

Nuremberg, Bavaria, Germany, 90419

Actively Recruiting

4

SLK-Kliniken Heilbronn GmbH - Fachklinik Löwenstein

Löwenstein, Germany, 74245

Not Yet Recruiting

Loading map...

Research Team

P

Prof. Dr. med. Simon Jäger

CONTACT

S

Simone Panzer

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here